John Veillette

Intermountain ID Telehealth/ASP Pharmacist. Views are my own.

[SIDP @SIDPharm]

Our next ADITL takes us to Intermountain Healthcare in Utah following Mary Hutton, PharmD! Be sure to keep up throughout the month as we approach #IDPharmacistsDay 💊🦠

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕️⚡️⚡️ @OFIDJournal
Real-World Effectiveness of Intravenous and Oral Antibiotic "Stepdown" Strategies for Gram-negative Complicated Urinary Tract Infection with Bacteremia #IDXposts https://t.co/8niuNZynAI

[Open Forum Infectious Diseases @OFIDJournal]

Oral Beta-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated Escherichia coli or Klebsiella species Bacteremia from a Urinary Source

✅ Just Accepted
🔓 Open Access
https://t.co/F2r9b4iwAG

via @jvilletti

[John Veillette @jvilletti]

@alzaidi_sameer @OFIDJournal @stephshealymay @m3rkat @tinymuscles Congrats Sameer!!

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕️🔥Multicenter observational cohort
Oral Beta-Lactams Fluoroquinolones, or Trim Sulfa for Definitive Rx of Uncomplicated E.coli or Klebsiella species Bacteremia from a Urinary Source
High-bioavailability βLs asociated w higher recurrence rates
BL Dose⛔️ https://t.co/V99hB0U6TC

[John Veillette @jvilletti]

@amykangIDpharm @accpinfdprn Congrats Amy!! Well deserved! 😊

[Infection Control & Hospital Epidemiology @ICHEJournal]

New from @whithartlage11 et al at @UWTASP:

Authors found that inappropriate treatment of asymptomatic bacteriuria is common in critical-access hospitals and highlight areas to focus stewardship initiatives in these settings

📄: https://t.co/CrrbDuLC6l

[SIDP @SIDPharm]

Put your hands together 👏🏻 for this week’s post of the newest @SIDPharm members! #SIDP #idtwitter #welcomewednesday

[John Veillette @jvilletti]

@LadowTiffany @DosingMatters @SIDPharm @blandman19 Thank you!!

[John Veillette @jvilletti]

@DosingMatters @SIDPharm @blandman19 Wow, thank you so much! 😊

[SIDP @SIDPharm]

You won't want to miss this session on maximizing #antimicrobial outcomes at #transitionofcare with presentations by @SIDPharm members @n_mercuro, @jvilletti, and @Sudamonas, moderated by @blandman19 and @ViridansPharmD! #IDWeek2023 @IDWeekmtg #SIDP2023 @accpinfdprn

[Journal of Hospital Medicine @JHospMedicine]

#Collaboration 🤝and #Telehealth🖥️ in #COVID19 rounds and stewardship decreased antibiotic use 💊and transfers 🚑without changing mortality!

https://t.co/yAwuReQgVO

@stephshealymay @jviletti @E_Stenehjem @tventoIDmd @SKThroneberry @SGelmanMD

#VisualAbstract by @CatieGlatz

[ASHE Journal @ASHE_Journal]

From @jvilletti, @stephshealymay et al from @IntermtnMedCtr: Another opportunity for ASP in the ED! Patients with BPCUS had ⬆️ readmissions despite abx. Key: Emphasize close f/u for an unknown diagnosis over abx treatment of a + urine! #stewardship https://t.co/MvhlwwZXbi

[Whitney Buckel @tinymuscles]

So proud of our PGY2ID resident @alzaidi_sameer! Great work under the mentorship of @jvilletti @stephshealymay @m3rkat

[John Veillette @jvilletti]

@EmilySpivak @tinymuscles @alzaidi_sameer @stephshealymay @m3rkat Hi Emily! Prelim data suggest the findings are actually similar. Working on the final analysis still, and we’ll be sure to share 🙂. Would love to discuss with you guys!

[Stephanie Shealy May @stephshealymay]

Very excited to share our tele-COVID intervention and the impact on early antibiotic use in @JHospMedicine. ITS demonstrated >5,000 antibiotic days avoided. Transfers were also significantly reduced.

https://t.co/iaVGQHO6UD

[Whitney Buckel @tinymuscles]

Impressed by the creativity Dustin - I hope this tune and your wisdom travel far and wide - I know I’ll be singing it in my head for a while. #antibioticstewardship #asb #IDTwitter #singalong #letitbe

[Stephanie Shealy May @stephshealymay]

Excited to share the impact of our tele ID program on SAB outcomes in small community hospitals in @OFIDJournal @jvilletti @tventoIDmd @E_Stenehjem @SGelmanMD @SKThroneberry
https://t.co/dBdmcCajTL

[Clinical Infectious Diseases @CIDJournal]

Antivirals with Activity Against Monkeypox: A Clinically Oriented Review

✅ Just Accepted
🔓 Open Access
🔗 https://t.co/SPk4a1pVrY